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Mechanotransduction pathways are activated in
response to biophysical stimuli during the develop-
ment or homeostasis of organs and tissues. In zebra-
fish, the blood-flow-sensitive transcription factor
Klf2a promotes VEGF-dependent angiogenesis.
However, the means by which the Klf2a mechano-
transduction pathway is regulated to prevent contin-
uous angiogenesis remain unknown. Here we report
that the upregulation of klf2mRNA causes enhanced
egfl7 expression and angiogenesis signaling, which
underlies cardiovascular defects associated with
the loss of cerebral cavernous malformation (CCM)
proteins in the zebrafish embryo. Using CCM-pro-
tein-depleted human umbilical vein endothelial cells,
we show that the misexpression of KLF2 mRNA re-
quires the extracellular matrix-binding receptor b1
integrin and occurs in the absence of blood flow.
Downregulation of b1 integrin rescues ccm mutant
cardiovascular malformations in zebrafish. Our
work reveals a b1 integrin-Klf2-Egfl7-signaling
pathway that is tightly regulated by CCM proteins.DevelopmThis regulation prevents angiogenic overgrowth
and ensures the quiescence of endothelial cells.
INTRODUCTION
During vertebrate embryogenesis, the basic morphology of the
cardiovascular system is established prior to the onset of blood
flow and is continuously modified in a process referred to as
angiogenesis (Herbert and Stainier, 2011; Geudens and Ger-
hardt, 2011). During angiogenesis, endothelial cells (ECs)
respond to biomechanical forces such as hemodynamics or
extracellular matrix stiffness (Mammoto et al., 2012; Freund
et al., 2012). These biophysical forces can modulate EC quies-
cence, the stabilization of cellular junctions, blood vessel lumen
formation, and the formation of endocardial cushions within the
heart. An important mediator of mechanosensitive responses to
blood flow within ECs is the zinc-finger transcriptional regulator
Kru¨ppel-like factor 2 (KLF2). Within developing zebrafish aortic
arch blood vessels, Klf2a activates a signaling cascade involving
the endothelial-specific microRNA miR-126a that promotes
VEGF-induced angiogenesis (Nicoli et al., 2010).
Another factor that has been implicated in blood vessel
morphogenesis and lumen formation is EGF-like domain, multi-
ple 7 (egfl7) (Parker et al., 2004), a secreted protein that isental Cell 32, 181–190, January 26, 2015 ª2015 Elsevier Inc. 181
associated with the blood vessel extracellular matrix (Soncin
et al., 2003; Fitch et al., 2004). That the egfl7 locus also encodes
mir-126 has complicated functional analyses of different mouse
models used to determine the roles of egfl7 and of miR-126 in
blood vessel development (Schmidt et al., 2007; Kuhnert et al.,
2008; Wang et al., 2008). Under physiological conditions, egfl7
is expressed in the vasculature (Parker et al., 2004) and its pro-
moter contains a putative Klf2-binding site (Harris et al., 2010).
Besides a proangiogenic activity, KLF2 also elicits a broad range
of transcriptional changes with a vasoprotective function within
ECs of mature blood vessels, and promotes the attachment
and stability of associated pericytes or vascular smooth muscle
cells (Lee et al., 2006; Dekker et al., 2006; Parmar et al., 2006).
Within the zebrafish heart, Klf2a is activated by reversible blood
flow patterns and is needed for the morphogenesis of functional
cardiac valves (Vermot et al., 2009) and endocardial cell morpho-
genesis (Dietrich et al., 2014). Despite its pivotal role for vessel
remodeling and integrity, neither the precise KLF2-mechano-
transduction-related-signaling pathway nor the mechanisms
involved in the shift from proangiogenic to vasoprotective
KLF2 activity are known.
Correct vascular development and integrity involve a complex
of proteins called cerebral cavernous malformation (CCM) pro-
teins, which have inhibitory roles during angiogenesis and atten-
uate Rho kinase signaling, which limits vascular permeability
(Faurobert and Albiges-Rizo, 2010; Fischer et al., 2013). A loss
of any of the three intracellular proteins, KRIT1/CCM1, CCM2/
OSM, or PDCD10/CCM3, results in CCMs (Fischer et al., 2013),
a group of vascular diseases characterized by cerebral hemor-
rhages that occur predominantly within low-flow venous capillary
beds and that lack typical vessel wall components, such as
pericytes and vascular smooth muscle cells (Zawistowski et al.,
2005; Voss et al., 2007; Zhang et al., 2007). Proteins of the
CCM complex assemble around the transmembrane protein
heart of glass (HEG) (Kleaveland et al., 2009). The entire CCM
protein complex is involved in endothelial junctional stabilization
and directly interacts with the vascular endothelial-Cadherin
complex (Glading et al., 2007). In addition, the CCM complex
represses the activity of b1 integrin by stabilizing KRIT1-
binding integrin-cytoplasmic-domain-associated protein 1
(ICAP1) (Faurobert et al., 2013;Macek Jilkova et al., 2014), a spe-
cific inhibitor of b1 integrin (Millon-Fre´millon et al., 2008) that as-
sociateswith KRIT1 (Zhang et al., 2001; Zawistowski et al., 2002).
b1 integrins are important players in mediating inside-out and
outside-in signaling between the intracellular milieu and the
extracellular matrix (Hynes, 2002; Ross et al., 2013), and play a
role in angiogenesis and vascular development (Avraamides
et al., 2008; Carlson et al., 2008; Lei et al., 2008; Tanjore et al.,
2008). A paralog of CCM2, CCM2L, recently has been implicated
as a promoter of cardiovascular growth byblockingCCM2-medi-
ated vascular integrity (Zheng et al., 2012). Upon lossof PDCD10/
CCM3, a separate mechanism involving germinal center kinase
III (Chan et al., 2011) or sterile 20-like kinases (Voss et al., 2007;
Zheng et al., 2010) has been implicated in defective vascular
or Drosophila tracheal tube development (Song et al., 2013). Un-
derstanding the precisemechanism by which CCMproteins pre-
vent uncontrolled angiogenesis and vessel leakage may provide
insights into the mechanisms by which angiogenesis is fine-
tuned during vascular maturation and in response to blood flow.182 Developmental Cell 32, 181–190, January 26, 2015 ª2015 ElseviHere, we show that the loss of CCM proteins results in a b1 in-
tegrin-dependent overexpression of klf2, which in turn causes an
upregulation of egfl7 and promotes angiogenesis. Our findings
imply that CCM proteins safeguard endothelial quiescence and
restrict proangiogenic signaling in the absence of blood-flow-
induced biophysical stimuli.
RESULTS
Overexpression of KLF2 mRNA Is a Conserved Feature
of CCM-Protein-Depleted ECs in Zebrafish, Mouse, and
HUVECs
A loss of CCM proteins causes a number of cardiovascular mal-
formations in zebrafish andmouse, including cardiac ballooning,
heart looping defects, a failure of endocardial cushions to form,
and defective blood vessel formation (Mably et al., 2003, 2006;
Hogan et al., 2008; Boulday et al., 2009; Kleaveland et al.,
2009; Zheng et al., 2010; Yoruk et al., 2012). To identify the tran-
scriptional changes responsible for such defects, we performed
a comparative transcriptome analysis using cardiac tissue,
which is rich in endocardial cells, isolated from ccm2m201mutant
andwild-type (WT) zebrafish embryos.We found that the two ho-
mologous blood-flow-responsive genes, klf2a and klf2b, were
upregulated in ccm2m201 mutant hearts; we confirmed the upre-
gulation of klf2a and klf2b in whole embryos at 48 hr postfertiliza-
tion (hrpf) by quantitative RT-PCR (qRT-PCR) (Figure 1A). To
assess whether the upregulation of klf2 expression upon loss
of CCM proteins is conserved in higher vertebrates, we next
analyzed the conditional endothelial deletion of murine CCM2
(iCCM2). The loss of CCM2 within ECs at postnatal day 1 (P1)
has been shown to cause CCM-like vascular defects with a com-
plete penetrance in the cerebellum and in the retina (Boulday
et al., 2011). Consistently, we found that Klf2 mRNA levels
were significantly elevated in the cerebellum of such iCCM2
animals at P15 (Figure 1B). Strikingly, in CCM2 siRNA-silenced
human umbilical vein endothelial cells (HUVECs), KLF2 mRNA
levels also were increased (Figure 1C). Hence, klf2 mRNA
overexpression is a conserved feature of CCM-protein-
depleted ECs.
To further elucidate whether klf2 overexpression is restricted
to particular regions of the zebrafish embryonic vascular
network, we next performed whole-mount in situ hybridizations.
This analysis revealed that klf2a and klf2b were strongly
overexpressed throughout the entire endocardium of zebrafish
krit1ty219c and ccm2m201 mutants (Figures 1D–1F; Figure S1
available online) and within arteries and veins of ccm2m201 mu-
tants at 48 hrpf (Figures 1G and 1H). Taken together, these find-
ings show that a loss of CCM proteins causes an upregulation of
klf2 mRNA within different regions of the vascular network.
Elevated Levels of klf2 Are Necessary and Sufficient to
Induce Cardiovascular Malformation Phenotypes
Associated with the Loss of CCM Proteins in Zebrafish
Klf2 proteins are blood-flow-responsive endothelial transcription
factors with essential roles in vasculogenesis, angiogenesis, car-
diac valve morphogenesis, regulation of vascular tone, and con-
trol of vasoprotective gene expression (Dekker et al., 2006; Lee
et al., 2006; Parmar et al., 2006; Vermot et al., 2009; Nicoli
et al., 2010). Based on the different cardiovascular functions ofer Inc.
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Figure 1. Loss of CCM Proteins Causes Elevated Levels of klf2
Expression
(A–C) Loss of Ccm2 causes elevated levels of klf2a and klf2b mRNA in ze-
brafish at 48 hrpf (A), ofKlf2mRNA inmouse cerebellar tissue of iCCM2mice at
P15 (B), and of KLF2 mRNA in HUVECs (C), as determined by qRT-PCR.
(D–H) At 48 hrpf, whole-mount in situ hybridizations show that klf2a is mis-
expressed within the entire endocardium of krit1ty219c and ccm2m201 mutants
(D–F) and is elevated within arteries and veins in the tail region (asterisk) of
ccm2m201 mutants (H) compared to WT embryos (G). Statistical data are
means and SEM; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; see Sup-
plemental Experimental Procedures for details about statistical data analysis.Klf2, we assessed whether high expression levels of klf2a and
klf2b may be causative for the ccm2m201 mutant cardiovascular
phenotype. The ccm2m201 cardiac phenotype is characterized
by cardiac ballooning, endocardial overproliferation, and by a
lack of cardiac cushions that normally form by 48 hrpf, as evi-
denced by the failure of endocardial cells to acquire a cuboidal
shape and to express activated leukocyte cell adhesion mole-
cule (Alcam) (Figures 2A, 2A’, 2B, 2B’, and 2J; Jin et al., 2005).
Within the ccm2m201mutant vasculature, the lateral dorsal aortas
(LDAs) exhibited significant increases in EC numbers at 48 hrpf,
providing evidence for increased angiogenesis signaling (Figures
2D, 2E, and 2J). Similarly, within the trunk region region of
ccm2m201mutants, the subintestinal vein (SIV) exhibited a higher
density of vessel branch points, which is another established
marker for increased angiogenesis (Figures 2G, 2H, and 2K; Yu
et al., 2010; Avraham-Davidi et al., 2012; Ghajar et al., 2013).
Strikingly, the partial reduction of both Klf2 proteins by coin-
jection of low doses of two antisense oligonucleotide morpholi-
nos (MOs) (5 ng each) completely restored endocardial cushion
formation, cardiac chamber morphogenesis, and even restored
some blood flow within the heart and major blood vessels in
ccm2m201, krit1ty219c, and hegm552 mutants (complete rescue
was observed for at least n > 50 embryos of each genotype veri-
fied by genotyping; high-resolution confocal images were re-
corded for n = 5 mutant embryos with invariant results) (FiguresDevelopm2C and 2C’; Figure S2). That low doses of both MOs were suffi-
cient for the rescue of cardiac morphology suggests that Klf2
protein levels are downregulated toward normal expression
levels by this injection regimen. In comparison, the injection of
high doses of MOs against either klf2a or klf2b (12 ng each) did
not rescue the cardiac phenotype of ccm2m201 mutants, which
shows that both Klf2 proteins are involved in the ccm mutant
phenotype (Figures S2A–S2H’). Consistent with the previous re-
sults, the low-dose knockdown of klf2a and klf2b in ccm2m201
mutants rescued endocardial and LDA cell numbers (Figures
2F and 2J) and reduced the number of SIV branch points (Figures
2I and 2K). Our results indicated that the two klf2 genes play a
central role in mediating the different cardiovascular malforma-
tions associated with the loss of CCM proteins.
To directly examine whether the induction of klf2a in WT
embryoswas also sufficient to phenocopy ccm2m201mutant car-
diovascular defects, we used stable transgenic lines for overex-
pression of klf2a from a friend leukemia integration 1a (fli1a)
promoter (Tg(fli1ep:GAL4FF)ubs2 [Herwig et al., 2011] and
Tg(UAS:klf2a)ig1–3). The continuous endothelial-specific overex-
pression of klf2a in these lines began at endocardial progenitor
stages, prior to heart formation, and caused a cardiac ballooning
phenotype between 48 and 72 hrpf with a high penetrance of
80% (n = 36/43 transgenic embryos of three independent F1
transgenic lines), comparable to the ccm2m201mutant cardiac
phenotype (Figures 2L and 2M). Similarly, ubiquitous overex-
pression of klf2a from a heat-shock promoter, induced at 15,
30, and again at 38 hrpf (Tg(hsp70l:klf2a)md8), resulted in
increased LDA cell numbers at 48 hrpf, comparable to those in
ccm2m201 mutants (Figure 2J). Taken together, the overexpres-
sion of klf2a/b in zebrafish is necessary and sufficient for the
expression of cardiovascular malformation phenotypes associ-
ated with the loss of CCM proteins.
Klf2 Promotes Proangiogenic Signaling and Increases
the Expression of Egfl7
Several lines of evidence suggest that aberrant angiogenesis
may be associated with the loss of CCM proteins. Human
CCM lesion growth is correlated with increased circulating con-
centrations of VEGF (Jung et al., 2003), mice heterozygous for a
mutation in CCM2 have increased vascular permeability in
response to VEGF injection (Whitehead et al., 2009), and angio-
genesis signaling is increased in ECs lacking CCM proteins
(Wu¨stehube et al., 2010; Zhu et al., 2010). In addition, the misre-
gulation of angiogenic VEGF signaling has an inhibitory effect on
cardiac cushion formation inmice (Dor et al., 2001). In agreement
with these observations, we found that several genes related to
angiogenesis signaling were upregulated in ccm2m201 mutant
compared with WT zebrafish cardiac transcriptomes (Table S1).
To determine whether ccm2m201 mutant cardiovascular de-
fects are due to aberrant angiogenesis, we inhibited VEGF
signaling in ccm2m201 mutants using the pharmacological com-
pound PTK787 (Chan et al., 2002). Under this antiangiogenic
condition, we observed a rescue of ccm mutant cardiovascular
defects, including cardiac cushion defects (Figures 3A–3C’)
and overproliferation defects of endocardium and LDA (Fig-
ure 3D). Based on this evidence, we also asked whether the
PTK787 inhibition of angiogenesis would affect klf2a/b mRNA
levels in ccm2m201 mutants, which was not the case (Figure 3E).ental Cell 32, 181–190, January 26, 2015 ª2015 Elsevier Inc. 183
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Figure 2. Elevated Levels of klf2 mRNA
Cause Morphogenetic Defects in Zebrafish
ccm Mutants
(A–I) Rescue of cardiac malformations, LDA de-
fects, and SIV defects in zebrafish ccm2m201 mu-
tants (B, B’, E, and H) by targeting klf2a/b with
MOs (C, C’, F, and I). (A–C) Shown are hearts of
different genotypes at 48 hrpf or (A’, B’, and C’)
details with single confocal plane sections of the
atrioventricular canal (AVC) region (arrowheads,
white box). Endocardial cushion cells are marked
by Tg(kdrl:GFP)s843 and Alcam staining (asterisks).
(D–F) Dorsal views of the LDA marked by
Tg(kdrl:GFP)s843 (inverted images) in different ge-
notypes at 48 hrpf. (G–I) Side view of the SIV
marked by Tg(kdrl:GFP)s843 in different genotypes
at 72 hrpf. Vessel branch point defects (arrows)
within the SIV are reduced by targeting klf2a/b in
ccm2m201 mutants (H and I).
(J) Endocardial and LDA cell numbers are elevated
in ccm2m201 mutants at 48 hrpf, as well as upon
overexpression of klf2a from a heat-shock-induc-
ible promoter.
(K) Quantifications of the number of branch points
of the SIV in different genotypes at 72 hrpf.
(L and M) Endothelial overexpression of klf2a in
Tg(fli1ep:Gal4FF)ubs2; Tg(UAS:klf2a)ig1–3; Tg(kdrl:
GFP)s843 transgenic embryos is sufficient to phe-
nocopy the ccm2m201 mutant cardiac ballooning
phenotype. Endo, endocardium; myo, myocar-
dium; A, atrium; V, ventricle. Scale bars, 25 mm.
Statistical data are means and SEM; ns, not sig-
nificant; *p < 0.05; **p < 0.01; ***p < 0.001; ****p <
0.0001; see Supplemental Experimental Pro-
cedures for details about statistical data analysis.Hence, klf2a/bmRNA expression is misregulated independently
of VEGFR-mediated angiogenesis in ccm2m201 mutants. Taken
together, our results indicate that Klf2 proteins promote proan-
giogenic signaling.
Of particular interest among the angiogenesis-related genes
that were upregulated upon loss of zebrafish Ccm2 was the
EGF-like-domain, multiple 7 (egfl7) gene (Parker et al., 2004),
which contains a putative Klf2-binding site (Harris et al., 2010).
We verified the increased expression levels of egfl7 in
ccm2m201 mutants by comparative qRT-PCR (Figure 4A). To
assess whether the overexpression of klf2 was sufficient to
induce higher levels of egfl7 expression, we induced klf2a/b
in Tg(hsp70l:klf2a)md8 or Tg(hsp70l:klf2b)md9 transgenic embryos
and found that, consistent with a regulation by klf2 genes,
the expression levels of egfl7 mRNA were increased under this
condition (Figure 4A). Similarly, in HUVECs, levels of EGFL7
were elevated upon silencing of ICAP1, KRIT1, or CCM2
(Figure 4B).
These findings suggested that egfl7 is regulated downstream
of Klf2, which prompted us to further elucidate its potential
involvement in ccm2m201 mutant cardiovascular malformations.
Strikingly, ccm2m201 mutant cardiovascular defects, including
the lack of cardiac cushions, were rescued upon using a low
dose of an egfl7 MO (0.6 ng) (Figures 4C–4E’). Hence, similar
to Klf2 proteins, high levels of Egfl7 mediate cardiovascular de-
fects associated with the loss of CCM proteins. To more directly
test whether klf2a/b and egfl7 interact genetically, we coinjected184 Developmental Cell 32, 181–190, January 26, 2015 ª2015 Elseviklf2a/b (2.5 ng each) and egfl7 MOs (0.3 ng) at low doses that
individually did not rescue the ccm2m201 mutant cardiovascular
phenotypes, including lumenization defects within interseg-
mental vessels that arise due to a lack of cardiac function (no
rescue among n > 50 ccm2m201mutants tested for eachMO; Fig-
ures S3D and S3E). The triple MO injection rescued the cardio-
vascular defects in ccm2m201 mutant embryos, as indicated
by the lumenization of intersegmental vessels (n = 19/21
ccm2m201mutants rescued, verified by genotyping; Figure S3C),
and further solidified our finding that klf2a/b and egfl7 act in a
common pathway.
Contrary to themisregulation of egfl7, neithermiR-126a (which
is required for aortic arch formation in zebrafish) nor miR-126b
(which is located within the egfl7 gene) were misregulated in
ccm2m201 mutants based on qRT-PCR experiments on 48 hrpf
whole embryos (Figure S4). Taken together, our results indicate
that Klf2 proteins promote VEGF-dependent proangiogenic
signaling, possibly by increasing the expression of Egfl7.
Overexpression of klf2 within CCM-ICAP1-Depleted
Endothelium Involves b1 Integrin but Is Independent of
Blood Flow
Within the zebrafish heart, Klf2a is activated in response to
reversible blood flow (Vermot et al., 2009). This finding raised
the question of whether another biophysical force-related mech-
anism might be involved in the induction of klf2a/b in ccm mu-
tants, since they have only severely reduced blood flow. Toer Inc.
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Figure 3. Enhanced VEGFR Signaling Is
Involved in the Zebrafish ccm2m201 Mutant
Cardiac Phenotype
(A–C) Rescue of cardiac malformations in
ccm2m201 mutants at 48 hrpf after treatment with
the VEGFR inhibitor PTK787 between 15 and
17 hrpf. (A–C) Shown are hearts marked by endo-
cardial Tg(kdrl:GFP)s843 and actin staining at
48hrpf or (A’,B’, andC’) detailswithsingleconfocal
plane sections of the AVC region (white box in A, B,
andC). Endocardial cushioncells arecharacterized
by their cuboidal shape (asterisks) (n = 5/5 geno-
typed ccm2m201 mutants completely rescued by
PTK787 treatment).
(D) Treatment of ccm2m201 mutants with PTK787
between 15 and 17 hrpf significantly reduces the
endocardial overproliferation phenotype, and
treatment between 24 and 48 hrpf suppresses the
overgrowth of the LDA.
(E) The phenotypic rescue of ccm2m201mutants by
treatment with PTK787 between 15 and 48 hrpf
does not affect the elevated expression levels of
klf2a and klf2b as detected by qRT-PCR. Endo,
endocardium; myo, myocardium. Scale bars,
25 mm. Statistical data aremeans and SEM; ns, not
significant; *p<0.05; **p<0.01; ***p<0.001; ****p<
0.0001; see Supplemental Experimental Pro-
cedures for details about statistical data analysis.determine whether klf2a/b expression is indeed flow-indepen-
dent in ccm mutants, we used a MO to knock down troponin
t2a (tnnt2a). The absence of Tnnt2a causes a loss of cardiac
contractility due to myofibrillar defects and a complete lack of
blood flow, which zebrafish embryos survive for several days
(Sehnert et al., 2002). We found that, under such no-flow condi-
tions, ccm2m201 mutant cardiac phenotypes (Figures 5A–5C)
and elevated klf2a and klf2bmRNA levels were not rescued (Fig-
ure 5D). Hence, expression levels of klf2a/b mRNA and the
occurrence of cardiovascular malformations in ccm2m201 mu-
tants are truly independent of the mechanical stimulation of
ECs by blood flow.
Time-lapse analyses between 33 and 53 hrpf of ccm2m201
mutant; tnnt2a morphants using light-sheet selective plane illu-
mination microscopy (SPIM) showed that the Ccm2-deficient
endocardium is highly proliferative in the absence of blood
flow, contrary to tnnt2a morphants (Figures 5E–5G; Movies S1
and S2). Similarly, human cerebral cavernoma form in venous
capillary beds that are characterized by low-blood-flow condi-
tions (Movie S3). Therefore, another stimulus rather than shear
stress must be involved in the activation of the KLF2 mechano-
transduction pathway in CCM-protein-depleted ECs.
In HUVECs, ICAP1 directly interacts with and attenuates the
activity of b1 integrin (Millon-Fre´millon et al., 2008; Faurobert
et al., 2013). Depletion of KRIT1 causes the destabilization of
ICAP1 protein resulting in increased b1 integrin activation (Faur-
obert et al., 2013). In addition, knockout of ICAP1 in mouse leads
to vascular defects, such as excessive branching and dilation
(Faurobert et al., 2013). To elucidate the potential involvement
of b1 integrin in KLF2-dependent mechanotransduction, we first
used HUVECs to assess KLF2 mRNA expression upon simulta-
neously silencing b1 integrin and either KRIT1, CCM2, or ICAP1.
We found that b1 integrin was required for high expression levelsDevelopmof KLF2 mRNA in CCM-protein-depleted HUVECs (Figure 6A;
efficacy of siRNA knockdowns is shown in Figure S5). In a com-
plementary set of experiments, we used an MO to downregulate
b1b integrin in zebrafish ccm2m201 mutants (Ablooglu et al.,
2010). Remarkably, low doses of b1b integrin MO rescued
cardiovascular malformations, including the loss of cardiac
cushions (n = 5/5 ccm2m201 mutant embryos rescued; Figures
6B–6D’). Taken together, these findings showed that b1 integrin
contributes to klf2 mRNA expression and promotes angiogen-
esis by enhancing Klf2 proangiogenic signaling. These findings
imply that CCMproteins attenuate angiogenesis signaling during
blood vessel maturation by negatively modulating the activity of
integrins.
DISCUSSION
Our study demonstrates that the shear-stress-sensitive tran-
scription factor Klf2 is amajor player inCCM-dependent vascular
development in zebrafish. We found that Klf2 is strongly overex-
pressed independently of blood flow when CCM proteins are
lost, and that b1 integrin is a signal triggering this elevated klf2
expression. Finally, we suggest that the proangiogenic activity
of Klf2 is based on the stimulation of Egfl7. These findings identify
the CCM complex as a key regulator of a b1 integrin-Klf2-Egfl7
mechanotransduction pathway in zebrafish. This regulation pre-
vents angiogenic overgrowth and ensures the quiescence and
differentiation of endothelial and endocardial cells. One impli-
cation of our findings is that extracellular matrix mechanics
mediated by b1 integrin signaling and cellular tension generated
within ECs could be sufficient to activate the mechanosensitive
transcription factor Klf2, even in a blood-flow-independent
manner. The misregulation of cellular tension in ccm mutants
may cause the developmental defects described in our study.ental Cell 32, 181–190, January 26, 2015 ª2015 Elsevier Inc. 185
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(A) Loss of Ccm2 or overexpression of klf2a/b in Tg(hsp70l:klf2a)md8 or
Tg(hsp70l:klf2b)md9 transgenic embryos causes elevated levels of egfl7
mRNA, as determined by qRT-PCR.
(B) Similarly, EGFL7 mRNA is upregulated in HUVECs upon knockdown of
ICAP1, KRIT1, or CCM2 by siRNA treatment.
(C–E’) Cardiac morphology and cardiac cushion formation are rescued by
egfl7 MO injection (n = 15/15 genotyped ccm2m201 mutants completely
rescued by egfl7 MO). Shown are hearts marked by endocardial
Tg(kdrl:GFP)s843 and actin staining at 48 hrpf or (C’–E’) details with single
confocal plane sections of the AVC region. Endocardial cushion cells are
marked by the expression of Alcam (inverted image) (asterisks). Scale bars,
25 mm. Statistical data are means and SEM; *p < 0.05; **p < 0.01; ***p < 0.001;
see Supplemental Experimental Procedures for details about statistical data
analysis.
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(A–C) The ccm2m201 mutant cardiac ballooning phenotype is flow indepen-
dent. Frontal views of 48 hrpf hearts of the myocardial reporter line
Tg(myl7:GFP)twu34 (Huang et al., 2003) show that cardiac expansion is not
rescued in ccm2m201 mutant; tnnt2a morphants that lack blood flow.
(D) The expression levels of klf2a and klf2bmRNA, as measured by qRT-PCR,
are elevated in ccm2m201 mutant; tnnt2a morphants that lack blood flow.
(E–G) Loss of Ccm2 results in overproliferation of the endocardium under no-
flow conditions. (E) Quantifications of the ratio of proliferating versus non-
proliferating endocardial cells between 33 and 53 hrpf in tnnt2a morphants
compared with ccm2m201 mutant;tnnt2a morphants based on SPIM re-
cordings (n = 2). (F) The endocardium of tnnt2a morphants is not proliferative
as indicated by the lack of color-coded proliferative cells (still image derived
from Movie S1, which is based on SPIM time-lapse recordings of endocardial
morphogenesis marked by Tg(kdrl:GFP)s843 between 33 and53 hrpf). (G) The
combined loss of Ccm2 and Tnnt2a is characterized by a high rate of prolif-
erative events (indicated by uniquely colored daughter cells derived from
proliferative events; still image derived from Movie S2). A, atrium; V, ventricle.
Statistical data are means and SEM; ns, not significant; *p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001; see Supplemental Experimental Procedures for
details about statistical data analysis.Given the current controversy on the function of Egfl7 in blood
vessel development, our work now provides further evidence
that expression levels of Egfl7 are an important factor in blood
vessel development. Initial functional studies suggested that
loss of egfl7 in mice and zebrafish causes vascular defects
(Parker et al., 2004; Schmidt et al., 2007). However, in mouse,
these phenotypes were later attributed to the inactivation of
miR-126 within the egfl7 locus (Kuhnert et al., 2008; Wang
et al., 2008). We showed here that elevated levels of egfl7 in
ccm2m201 mutants correlate with abnormal angiogenesis and
that downregulating the expression levels of egfl7 rescues the
mutant cardiac phenotype. This finding is in tune with a report
that overexpression of egfl7 specifically in ECs induces cardiac
and blood vessel defects in mice (Nichol et al., 2010). In compar-
ison,miR-126a ormiR-126b were not misregulated in ccm2m201
mutants. We conclude that the elevated expression levels of
klf2 and egfl7 mediate the ccm phenotype independently of
miR-126.
Previous studies have not explained why mature, postangio-
genic, and well-perfused blood vessels are largely resistant to
the loss of CCM proteins in mice. Instead, the loss of CCM
proteins mainly affects low-blood-flow venous capillary beds.
Our study indicates that KLF2 could be a player in this186 Developmental Cell 32, 181–190, January 26, 2015 ª2015 Elsevipathology since it controls EC gene expression in response to
blood flow with biphasic roles depending on the biological
context. Within regions of high laminar shear stress, the
induction of KLF2 establishes vasoprotective gene expression
within vessel walls (Dekker et al., 2006; Parmar et al., 2006),
explaining why high-shear-stress regions of the humaner Inc.
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Figure 6. Misexpression of KLF2 Depends
on Integrin b1
(A) qRT-PCR shows that elevated expression of
KLF2mRNA in ICAP1-, KRIT1-, or CCM2-silenced
HUVECs is partly suppressed upon simulta-
neously interfering with b1 integrin (ITGB1).
(B–D) Morpholino knockdown of zebrafish
integrinb1b completely restores cardiac mor-
phology (marked by Tg(kdrl:GFP)s843 and actin
staining) and cardiac cushion formation in zebra-
fish ccm2m201 mutants at 48 hrpf. (B’–D’) Shown
are single confocal plane sections with details of
the AVC region (white box in B–D) with endocardial
cushion cells as marked by actin (asterisks).
(E) Model of CCM/ICAP1-controlled proangio-
genic activity of the b1 integrin-Klf2 mechano-
transduction pathway. Endo, endocardium; myo,
myocardium. Scale bars, 25 mm. Statistical data
are means and SEM; ns, not significant;***p <
0.001; ****p < 0.0001; see Supplemental Experi-
mental Procedures for details about statistical
data analysis.vasculature are mostly protected from CCM-like lesions. In
contrast, lowly perfused small venous capillary beds may be
more prone to vascular malformations due to the proangiogenic
role of KLF2 (Nicoli et al., 2010), which is enhanced by b1 integ-
rin. In support of this model, data obtained in constitutive embry-
onic iCCM2 knockout mice reveal strong developmental pheno-
types within the cardiovascular system under impaired low-flow
conditions. Mice targeted postnatally, in which high-flow condi-
tions within the heart and arteries have been established, show
only capillarovenous disease-like phenotypes (Boulday et al.,
2011). In principle, low-blood-flow and hypoxic conditions or
proangiogenic stimuli from neighboring tissues may enhance a
proangiogenic KLF2 response that perpetuates the formation
of CCM lesions. A number of studies have suggested that hypox-
ic conditions in older patients (Denier et al., 2006; Labauge et al.,
2007) or signaling from neural tissue may trigger the develop-
ment of CCM lesionswithin neighboring venous capillaries (Louvi
et al., 2011).
Our work introduces the idea that the CCM complex has an
essential role in limiting b1 integrin-mediated expression of
KLF2 in ECs, thereby attenuatingVEGF-dependent angiogenesis
signaling (Figure 6E). Future research should reveal whether this
pathway is relevant for other vascular pathologies as well. For
instance, genetic and molecular evidence from inheritable forms
of aneurysms points to an involvement of aberrant TGF-b
signaling in these vascular diseases (Pardali et al., 2010; LindsayDevelopmental Cell 32, 181–190and Dietz, 2011). Intriguingly, murine
KLF2 knockout animals frequently pre-
sent with aortic aneurysms (Kuo et al.,
1997). Aberrant TGF-b (Pardali et al.,
2010; Lindsay and Dietz, 2011; Madda-
luno et al., 2013) or angiogenesis (Wu¨ste-
hube et al., 2010) signaling is found in a
plethora of vascular diseases including
CCMs. Our work now opens an intriguing
possibility that inappropriate changes in
KLF2 may lie at the heart of many otherpathologies of the human vasculature, under conditions of both
low blood flow (leading to an enhanced proangiogenic KLF2 ac-
tivity) and high blood flow (where there is a loss of vasoprotective
KLF2 activity).
EXPERIMENTAL PROCEDURES
Zebrafish Lines and Handling
Handling of zebrafish was done in compliance with German and Berlin state
law, carefully monitored by the local authority for animal protection (LaGeSo).
All procedures performed in mice received the agreement of the French
Animal Ethical Committee no. 9 of the University (protocol number
CEEALV:2012-04-01). The following strains were maintained under standard
conditions as previously described (Westerfield et al., 1997): ccm2m201 (Mably
et al., 2006), krit1ty219c (Mably et al., 2006), hegm552 (Mably et al., 2003),
Tg(myl7:GFP)twu34 (Huang et al., 2003), Tg(kdrl:GFP)s843 (Jin et al., 2005),
Tg(fli1a:GAL4FF)ubs2 (Herwig et al., 2011), Tg(UAS:KLF2a)ig1–3, Tg(hsp70l:
klf2a_IRES_EGFP)md8, and Tg(hsp70l:klf2b_IRES_EGFP)md9–11. The following
morpholinos were used: klf2a (GGACCTGTCCAGTTCATCCTTCCAC) (Nicoli
et al., 2010), klf2b (AAAGGCAAGGTAAAGCCATGTCCAC), tnnt2a (CATGT
TTGCTCTGATCTGACACGCA) (Sehnert et al., 2002), and itgb1b (GCCAGTTT
GAGTGAATAACTCACCT) (Ablooglu et al., 2010). See Supplemental Experi-
mental Procedures for details on morpholino injections, heat-shock and phar-
macological treatment conditions.
Generation of Transgenic Lines of Zebrafish
Each of the transformation plasmids was coinjected with the Tol2 transpo-
sase-capped mRNA synthetized using the SP6 polymerase (mMessage
Machine, Ambion) into one-cell-stage zebrafish embryos. Several, January 26, 2015 ª2015 Elsevier Inc. 187
independent transgenic lines were established for each construct. In func-
tional tests, these independent lines resulted in comparable phenotypes.
Immunohistochemistry
For zebrafish whole-mount immunohistochemistry, the following antibodies
were used: mouse Zn-8/Alcam (1:100; Developmental Studies Hybridoma
Bank); Cy5-conjugated secondary antibody goat-anti-mouse (1:250; Jackson
ImmunoResearch Laboratories 96829); and rhodamine phalloidinewas used to
stain actin (1:100; Sigma 658740). For details, also on quantifications of endo-
cardial and LDA cell numbers, see Supplemental Experimental Procedures.
Pharmacological Treatment
Embryos were treated in E3 medium with 12.5 mM VEGFR inhibitor PTK787
(Chan et al., 2002). Control embryos were treated with 0.01% DMSO.
Treatment protocols corresponding with different figures were as follows:
(1) between 15 and 17 hrpf (shown in Figures 3C and 3C’; Figure 3D, only endo-
cardium); and (2) between 24 and 48 hrpf (shown in Figure 3D, only LDA;
Figure 3E).
Whole-Mount In Situ Hybridizations
Zebrafish embryos were collected at 48 hrpf, fixed with 4% paraformaldehyde
overnight at 4C, and in situ hybridization with klf2a and klf2b in situ probes
was performed as described elsewhere (Jowett and Lettice, 1994). For details,
see Supplemental Experimental Procedures.
qRT-PCR
To determine klf2 expression levels, qRT-PCRexperimentswere performed on
zebrafish whole embryos, on iCCM2 mouse cerebella (Boulday et al., 2009),
and on HUVECs in compliance with the MIQE standard (Bustin et al., 2009).
See Supplemental Experimental Procedures for details on samples, condi-
tions and primers used for qRT-PCR, and data analysis.
SPIM Imaging
SPIM imaging was performed with zebrafish tnnt2amorphants and ccm2m201;
tnnt2a mutant/morphant embryos harboring the Tg(kdrl:GFP)s843 transgene
between 33 and 53 hrpf. See Supplemental Experimental Procedures for
details on samples and analysis of the recordings.
iCCM2Mice
Endothelial-specific conditional CCM2 knockout mice Cadh5(PAC)-
CreERT2/+; Ccm2 Fl/Del., referred to as iCCM2, were treated with tamoxifen
at P1 to induce the endothelial-specific deletion of Ccm2 (Boulday et al.,
2009).Cadh5(PAC)-CreERT2/+mice were treated identically and used as con-
trols. Mice were sacrificed at P15, the brains were prepared, snap-frozen, and
the cerebella (in iCCM2 mice, these harbor cavernomas) were subsequently
isolated for RNA extraction.
Video Angiography during Neurosurgical Procedures
Video angiography of a human cavernoma was performed during a neurosur-
gical procedure as previously described (Raabe et al., 2003). See Supple-
mental Experimental Procedures for further details.
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